Product Liability Lawyer Blog

January 17, 2016

FDA Issues Press Release about Transvaginal Mesh (TVM) Dangers

The United States Food and Drug Administration (FDA) has recently issued a press release dealing with new changes to regulations regarding the use of transvaginal mesh (TVM) implants.

Surgical mesh has been around for decades. In the 1950s, surgeons used the material to repair hernias. Two decades later, surgeons began experimenting with the use of surgical mesh to treat a serious medical condition in women known as pelvic organ prolapse (POP). However, at that time, surgeons would make an incision in the patient’s abdomen to implant the mesh, and this led to a longer and more painful recovery than many patients would have liked. Continue reading

January 15, 2016

More Trouble with Xarelo Clinical Trials

by Jeffrey S. Glassman

Xarelto has come under a lot of fire lately, as thousands of people have developed a deadly internal bleeding disorder after taking the anticoagulant, and more than 60 people have died. The basis of these claims are that the makers of Xarelto, Bayer and Janssen (a division of Johnson & Johnson), designed a defective drug and failed to adequately warn plaintiffs of a danger about which they knew or should have known.

Xarelto is a member a relatively new class of drugs known as New Oral Anticoagulants (NOACs), which were designed to compete with traditional blood thinning medications such as Coumadin (Warfarin). Warfarin is a blood thinner that is prescribed to many patients who suffer from a serious medical condition know as atrial fibrillation (Afib). Afib is basically an irregular heartbeat, which can lead to the formation of clots in the deep veins of the legs. If the clots break free, they can travel through the body until they puncture the lungs or cause a stroke if the blood supply to the brain is blocked. When a clot punctures a patient’s lung, this is known as a pulmonary embolism (PE). Continue reading

January 12, 2016

Victim Filed Lawsuit against Johnson & Johnson for Defective Hip

by Jeffrey S. Glassman

Hip replacement surgery operations were once reserved for elderly patients who could no longer walk and those with a traumatic injury to the hip joint. These days, hundreds of thousands of total hip replacement procedures are being performed each year, and the trend seems to be increasing every year. Doctors are performing the surgery on younger patients who have developed arthritis from sports injuries and normal wear and tear. With more an more people engaging in activities like long distance running, including running marathons, it is no wonder we are seeing higher rates of joint disease. While running may keep you get in shape, it can be very hard on your joints.

Most doctors who perform these procedures are well-trained and competent surgeons who properly advise a patient of the risks and then perform as close to perfect a total hip replacement as possible. While there is going to a be a lot of pain and discomfort and a long recovery period, most patients end up very happy with the results. Continue reading

January 9, 2016

Drug Company Hopes Xarelto Can Finally Overtake Warfarin Due to Antidote

by Jeffrey S. Glassman

With the regular NFL season coming to close and playoffs heating up, there will be more people watching football than at any other point in the season. This will, of course, culminate with Super Bowl 50. During the Super Bowl, many will tune in for the big game and others will come just for the commercials. Super Bowl commercials are such a big draw that advertisers will pay over $10 million for a single 30-second spot.

As we have seen during the regular season, we can expect to see commercials for Xarelto, along with Pradaxa and Eliquis, and possibly Savaysa. These are all members of a new class of drugs called New Oral Anticoagulants (NOAC). They are prescribed for patients who suffer from a serious, but manageable health condition known as atrial fibrillation (Afib). Afib patients have an irregular heartbeat that causes large clots to form deep within in the veins of the legs in a condition known as deep vein thrombosis (DVT). When one of these clots breaks free where it has formed, it can travel through the bloodstream causing disastrous results. It can puncture a hole in the lungs known as a pulmonary embolism (PE) that can be deadly. The clots can also block the flow of blood to the brain, causing a stroke. Continue reading

January 7, 2016

Mary Meeks v. Hologic, Inc.: Defective Medical Devices

by Jeffrey S. Glassman

Mary Meeks v. Hologic, Inc., a case from the Supreme Court of Mississippi, involved a doctor at a women’s clinic who performed an outpatient diagnostic procedure known as a hysteroscopy as well an endometrial ablation on the plaintiff. During this procedure, her doctor used a Novasure medical device. Hologic is the medical device company that manufactures Novasure.

Two days after having the medical procedure, plaintiff went back to the medical center complaining of vomiting, nausea, and pain in her abdomen. Doctors did an initial test and determined plaintiff had a perforated uterus and the surrounding wall was blanched in a manner consistent with being burned. Continue reading

January 4, 2016

Yates v. Ortho-McNeil-Janssen Pharma., Inc: Defective Drug Lawsuits

by Jeffrey S. Glassman

Yates v. Ortho-McNeil-Janssen Pharma., Inc, a case from the United States Court of Appeals for the Sixth Circuit, involves a plaintiff who began going to her OB/GYN when she was 17 years old in 2004. She first went to the doctor because she was sexually active and was experiencing menstrual cramps.

Her doctor spoke with her about her choices for contraceptives and discussed the risks associated with each of the options. One of the choices for birth control was ORTHO EVRA and another was Depo-Provera. The doctor testified that she customarily warned all patients about the risks of taking birth control before writing a prescription. Continue reading

January 1, 2016

Weight Loss Surgery Before Knee Replacement Surgery may Reduce Complications

by Jeffrey S. Glassman

Knee replacement surgery is becoming more and more popular in the United States each and every year. While the procedure was traditionally done as an elective surgery for elderly patients who could no longer stand to live with their arthritis pain that had become quite severe, today, younger patients are having the procedure done to cope with arthritis and injury caused by athletic activities like long distance running.

There is no question that having a knee replaced is a major undertaking, and there is going to be great deal of pain and suffering during the recovery period. However, if the artificial knee itself was defectively designed, there is obviously a much higher chance patients will have significant complications, including a total device failure. This will cause the need for a second or Continue reading

December 31, 2015

FDA Approves Pradaxa for Hip Replacement Patients

by Jeffrey S. Glassman

Pradaxa is a medication used to reduce the risk of serious clotting disorder in patients who suffer from a potentially serious medical condition known as atrial fibrillation (Afib). Afib patients are at higher risk for forming large blood clots deep within the veins on their legs and other extremities. These blood clots can form in the legs and then break lose and travel through a patient’s circulatory system, which is another deadly medical condition, know as Deep Vein Thrombosis (DVT).

When a DVT clot travels through the circulatory system, it can become lodged in the lungs and tear a hole known as a pulmonary embolism (PE) or block the blood to the brain, causing a stroke. To reduce this risk, patients need either a traditional blood thinner like warfarin (Coumadin) or one of the new anticoagulants like Pradaxa, Eliquis, Xarelto, or Savaysa. Continue reading

December 28, 2015

Daniel v. Ford Motor Company: Products Liability Cases

by Jeffrey S. Glassman

Daniel v. Ford Motor Company, a case from the United States Court of Appeals for the Ninth Circuit, involved a plaintiff who filed a class action lawsuit against defendant in which he alleged that defendant breached its implied and express warranties and also engaged in fraud when selling vehicles with a defectively manufactured rear suspension system.

In the Uniform Commercial Code (UCC) as adopted by the Commonwealth of Massachusetts, any merchant who sells a product to a consumer makes an implied warranty of merchantability. In this context, merchant means a regular seller of goods of a type. For example, if you buy a toaster oven from Sears, they are regular seller of that item and are therefore a merchant of goods of that kind. On the other hand, if you buy a lawnmower off Craigslist, it is more likely than not that the seller of the lawnmower was a not a lawnmower dealer but was simply selling his or her own used lawnmower. Since the seller is not a merchant, he or she is not giving an implied warranty of merchantability. However, he or she would still be liable for negligence if there was a known defect that caused a personal injury to buyer, and that known defect was never disclosed. Continue reading

December 24, 2015

Are Boston Injured Victims Bringing Enough Product Liability Claims?

by Jeffrey S. Glassman

Tort reform advocates argue Americans are too litigious and aim for limitations on the rights of consumers to sue. Clauses built into consumer product purchase agreements limiting class action rights and mandating arbitration are some of many ways in which companies aim to limit the litigation they are exposed to. News stories are also released purporting to show frivolous lawsuits in order to raise suspicions about the legitimacy of claims based on product defects- even though the facts often show these lawsuits are not actually frivolous at all.

Consumer advocate Ralph Nader is fighting back against the misconceptions that are being pushed by big business. In a recent interview published in Parade Magazine, Nader argued there are actually not enough cases being brought to hold manufacturers accountable when they cause harm to the public.

Injured Victims are Not Bringing Enough Product Liability Lawsuits